Zobrazeno 1 - 10
of 99
pro vyhledávání: '"W.J.W. Morrow"'
Publikováno v:
Vaccine. 22:2380-2384
Soluble or sub-unit protein vaccines alone are incapable of generating antigen-specific cellular immune responses. This failure can be attributed to the manner in which the immune system processes antigen; endogenous antigens are cycled through the M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8b9a04fb58b010ad8e32235f23dbea
https://doi.org/10.1016/j.vaccine.2004.03.022
https://doi.org/10.1016/j.vaccine.2004.03.022
Publikováno v:
Vaccine. 22:1524-1536
Many vaccine adjuvants contain surface-active agents, but the immunological roles played by these components have been essentially ignored. The objective of this study was to examine possible apoptotic and necrotic effects of the surface-active agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2260d2e8f509199de07b2279e987662c
https://doi.org/10.1016/j.vaccine.2003.08.048
https://doi.org/10.1016/j.vaccine.2003.08.048
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E
Publikováno v:
Vaccine. 20:1308-1315
The gE glycoprotein of varicella zoster virus (VZV) is involved with cell entry and it is the most abundant glycoprotein produced in VZV-infected cells. It is also the first glycoprotein to be recognized by the immune system and induces neutralizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3743e1ad264a7b66d692a02831e0f2b8
https://doi.org/10.1016/s0264-410x(01)00475-3
https://doi.org/10.1016/s0264-410x(01)00475-3
Publikováno v:
Urologia Internationalis. 69:219-226
Background/Methods: In this study, immunobead purification, dot-blot, immunocytochemical staining, and SDS-PAGE techniques in combination with high-performance liquid chromatography were used to isolate human leukocyte antigen (HLA) class I antigens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff4dc5d3b48d7b5f3996b79e3e0b898
https://doi.org/10.1159/000063943
https://doi.org/10.1159/000063943
Publikováno v:
Journal of Immunological Methods. 229:1-22
A radical change in vaccine methodology arrived nine years ago with the advent of nucleic acid immunization. Aspects such as plasmid design, gene selection, the use of immunostimulatory complexes and clinical trials are discussed in this review. Furt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ecffb7e344ccdf82c4f0bbd8c30a4e
https://doi.org/10.1016/s0022-1759(99)00104-0
https://doi.org/10.1016/s0022-1759(99)00104-0
Publikováno v:
Vaccine. 22(17-18)
Tomatine adjuvant, consisting of tomatine, n-octyl-beta-d-glucopyranoside (OGP), phosphatidylethanolamine and cholesterol is unique in that when combined with soluble protein antigen it elicits a cytotoxic T lymphocyte (CTL) response in immunized ani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0b23bc340b1d587d1923ecaf9ee113
https://pubmed.ncbi.nlm.nih.gov/15149791
https://pubmed.ncbi.nlm.nih.gov/15149791
Publikováno v:
Biomaterials. 23(23)
The tomatine adjuvant, consisting of tomatine, n -octyl- β - d -glucopyranoside, phosphatidylethanolamine, cholesterol, and ovalbumin, has recently been shown to potentiate the immunogenicity of protein antigen and elicit cytotoxic T-lymphocyte resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c530a9009257f3ce3a8e3e837a3a617
https://pubmed.ncbi.nlm.nih.gov/12322989
https://pubmed.ncbi.nlm.nih.gov/12322989
Publikováno v:
Vaccine. 17(23-24)
Presentation of peptide on MHC class I molecules is essential to elicit cytolytic T cell (CTL) activity. Such peptides are a result of the cytosolic, or class I, antigen processing pathway. Due to the segregation of the class I and the exogenous proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c06051a5865aa0f5692fbf2e81674e
https://pubmed.ncbi.nlm.nih.gov/10462232
https://pubmed.ncbi.nlm.nih.gov/10462232
Publikováno v:
Trends in Immunology. 22:225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::748dbed1dd78b04856113f2151e4e856
https://doi.org/10.1016/s1471-4906(01)01886-5
https://doi.org/10.1016/s1471-4906(01)01886-5
Publikováno v:
Urologia Internationalis; Apr2003, Vol. 70 Issue 3, p154, 7p